期刊文献+

白念珠菌菌丝相和酵母相ERG11基因部分序列差异性的探讨 被引量:11

The DNA Sequence Difference of ERG11 Gene Between the Yeast-form and the Hyphal-form of Candida albicans
原文传递
导出
摘要 目的研究白念珠菌菌丝相和酵母相细胞ERG11基因碱基序列上的差异,探讨两相细胞之间的差异性。方法分别抽提从同一HIV阳性患者体内分离到的7株对氟康唑敏感程度不同的白念珠菌菌丝相和酵母相的DNA,此系白念珠菌经染色体水平及DNA水平证实来源于同一亲本。根据ERG11编码序列设计一对引物,对ERG11的近3'端的310bp的碱基序列进行PCR扩增,引物序列为:上游引物5'-GGGAAAGTTTCTAAAGGGG-3';下游引物5'-TATGTTAATCCAACTAAGTAA-3'。经PCR产物直接测序比较两相细胞ERG11基因碱基序列上的差异。结果1株氟康唑剂量依赖性敏感和2株氟康唑耐药白念珠菌的菌丝相与酵母相细胞间均出现ERG11基因1547位点、1587位点和1617位点的不一致。结论白念珠菌的菌丝相和酵母相ERG11基因的部分序列存在差异。 Objective To explore the difference of gene sequence between the yeast- and the hyphal-form of Candida albicans. Methods The genomic DNA of both the yeast-form and the hyphal-form of seven isolates were extracted. The isolates were obtained from the same patient infected with HIV, but their sensitivities to fluconazole were different. These isolates were derived from the same C.albican strain as identified by chromosomal analysis and DNA subtype analysis. DNA fragments (310 bp) of ERG11 were amplified by PCR and the difference of DNA sequence between the two forms of each isolates was compared by DNA sequencing. Results Three isolates were found to have sequence difference between the yeast- and the hyphal-form of C. albicans at the position of 1 547 bp, 1 587 bp and 1 617 bp. Conclusion The sequence difference of ERG11 gene exists between the yeast- and the hyphal-form of C. albicans.
作者 石婧 张宏
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2004年第8期472-474,共3页 Chinese Journal of Dermatology
基金 广东医学科研基金资助(A1999300)
关键词 白念珠菌 菌丝相 酵母相 ERGl1基因 基因序列 差异性 Candida albicans Hyphae Yeast-form Genes, fungal
  • 相关文献

参考文献9

  • 1王文莉,李若瑜,王端礼,万哲,王晓红,李世荫,朱立煌.念珠菌对唑类药物耐药机理的探讨[J].中华皮肤科杂志,1997,30(5):306-309. 被引量:16
  • 2White TC, Marr KA, Bowden RA. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev, 1998, 11: 382-402.
  • 3牛云彤,李少平.白念珠菌毒力因子研究进展[J].中国微生态学杂志,2000,12(1):60-61. 被引量:6
  • 4White TC. The presence of an R467K amino acid substitution and loss of allelic variation correlate with an azole-resistant lanosterol 14 alpha demethylase in Candida albicans. Antimicrob Agents Chemother, 1997, 41: 1488-1494.
  • 5Redding S, Smith J, Farinacci G, et al. Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis. Clin Infect Dis, 1994, 18: 240-242.
  • 6White TC, Pfaller MA, Rinaldi MG, et al. Stable azole drug resistance associated with a substrain of Candida albicans from an HIVinfected patient. Oral Dis, 1997, 3 Suppl 1: S102-109.
  • 7Ponton J, Jones JM. Analysis of cell wall extracts of Candida albicans by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and Western blot techniques. Infect Immun, 1986, 53: 565-572.
  • 8Liu H. Transcriptional control of dimorphism in Candida albicans.Curr Opin Microbiol, 2001, 4: 728-735. [9]Schaude M, Ackerbauer H, Mieth H. Inhibitory effect of antifungal agents on germ tube formation in Candida albicans. Mykosen, 1987,30: 281-287.
  • 9Schaude M,Ackerbauer H,lnhibitory effect of antifungal agents on germ tube formation in Candida albicans.Mykosen, 1987,30:281-287.

二级参考文献10

  • 1[1]De repentigny,L M Phaneuf.Gastrointestion colonization and systemic dissemination by Candida albicans and Candida tropicalis inintact and immun0-com promi sed mice.Infect Immun,1992,60:4907.
  • 2[2]D Domenico,V Beatrice.A nosocomial cluster of Candida inconspicus in fection in patients with Hematological malignancies.J Clin Microbiol,1998,36(3),794.
  • 3[3]L.Goegl,M.Ollert,Korting.The role of Candida albicans sevreted asp artic proteinase in the development of candidoses.J Mol Med,1996,74:135~142.
  • 4[4]De Bernardis,R P chiani,M Calccuzzi.P.Elevated aspartic proteinase scretion and experimental pathorgenicity of Candida albicans isolated form oral cavitics of subjects intected with human immunodeficiency virus.Infect Immun,1996,64:466.
  • 5[5]S Dominique H Bernhard.Triple Deletion of the secreted aspartyl prote inase Genes SAP 4,SAP5,and SAP6 of Candida albicans causes attenuated virulenc e.Infection and Immunity,1997,65(9):3539.
  • 6[6]White T,N.Agahian.Candida albicans secreted aspartyl proteinases:is renzyme pattern is determined by cell type and levels are determined by envirome ntal fators.J Bacteriol,1995,177:5215~5221.
  • 7[7]Antifungal drugtargets: Candida secreted aspartyl protease and fungal wall beta-glucan synthesis Goldman-RC.Infect Agents Dis,1995,4(4)228~47.
  • 8[8]Calderone RA,Braun PC.Adherence and receptor relationship of Candid a abicans.Microbiol Rev,1991,55:13CR2.
  • 9[9]F.C odds,Dro Frank,C odds.Swich of phenoctype as anescape mechanism of the intruder.J Med Vet Mycol,1998,26:173.
  • 10[10]A.M Ghannoum.Extracellular Phospholipawew as universal virulence fact or in patrhogenic fungi.Jpn J Med Mycol,1998,39(2):55.

共引文献20

同被引文献65

引证文献11

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部